1. 107. A Phase 3, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Oteseconazole (VT-1161) Oral Capsules versus Fluconazole and Placebo in the Treatment of Acute Vulvovaginal Candidiasis Episodes in Subjects with Recurrent Vulvovaginal Candidiasis (ultraViolet). (4th December 2021) Authors: Martens, Mark G; Maximos, Bassem; Degenhardt, Thorsten; Person, Karen; Curelop, Stacey; Ghannoum, Mahmoud; Brand, Stephen Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 719. Susceptibility Testing of Oteseconazole (VT-1161) Against Clinical Isolates from Phase 3 Clinical Studies in Subjects with Recurrent Vulvovaginal Candidiasis. (4th December 2021) Authors: Ghannoum, Mahmoud; Degenhardt, Thorsten; Person, Karen; Brand, Stephen Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S459 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗